. Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1␣ in rat heart. Am J Physiol Heart Circ Physiol 297: H1274 -H1280, 2009. First published August 14, 2009 doi:10.1152/ajpheart.00503.2009.-Mechanical load and ischemia induce a series of adaptive physiological responses by activating the expression of O 2-regulated genes, such as hypoxia inducible factor-1␣ (HIF-1␣). The aim of this study was to explore the interaction between HIF-1␣ and soluble guanylate cyclase (sGC) and its second messenger cGMP in cultured cardiomyocytes exposed to hypoxia and in pressure-overloaded heart. In cultured cardiomyocytes of neonatal rats, either sGC stimulator BAY 41-2272 or cGMP analog 8-bromo-cGMP decreased the hypoxia (1% O 2/5% CO 2)-induced HIF-1␣ expression, whereas the inhibition of protein kinase G by KT-5823 reversed the effect of BAY 41-2272 on the expression under hypoxic conditions. In pressure-overloaded heart induced by suprarenal aortic constriction (AC) in 7-wk-old male Wistar rats, the administration of BAY 41-2272 (2 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 ) for 14 days significantly suppressed the protein expression of HIF-1␣ (P Ͻ 0.05), vascular endothelial growth factor (P Ͻ 0.01), and the number of capillary vessels (P Ͻ 0.01) induced by pressure overload. This study suggests that the pharmacological sGC-cGMP stimulation modulates the HIF-1␣ expression in response to hypoxia or mechanical load in the heart. cyclic guanosine monophosphate; hypoxia; mechanical load; angiogenesis; inflammation THE MYOCARDIUM IS AN elastic network of cardiomyocytes enmeshed in a collagen matrix that connects the myocytes and supporting intramyocardial coronary vasculature. Mechanical load or ischemia induces a series of adaptive physiological responses in the heart [cardiomyocyte hypertrophy, interstitial fibrosis, and angiogenesis (24, 29)]. Hypoxia inducible factor-1 (HIF-1) is one of the most important transcription factors, composed of following subunits: a constitutively expressed HIF-1␤ and HIF-1␣ induced by hypoxia, and the latter subunit induces the expression of a number of downstream genes, including that for the vascular endothelial growth factor (VEGF) (26). Expressions of HIF-1␣ and VEGF are reported to be activated in hypertrophied and failing heart (17, 26, 29, 30) , and the increased number of capillary vessels penetrating the interstitial spaces contribute to supply oxygen and nutrients to the cardiocytes for maintaining the structure and function of pressure-overloaded heart (29, 34).
THE MYOCARDIUM IS AN elastic network of cardiomyocytes enmeshed in a collagen matrix that connects the myocytes and supporting intramyocardial coronary vasculature. Mechanical load or ischemia induces a series of adaptive physiological responses in the heart [cardiomyocyte hypertrophy, interstitial fibrosis, and angiogenesis (24, 29) ]. Hypoxia inducible factor-1 (HIF-1) is one of the most important transcription factors, composed of following subunits: a constitutively expressed HIF-1␤ and HIF-1␣ induced by hypoxia, and the latter subunit induces the expression of a number of downstream genes, including that for the vascular endothelial growth factor (VEGF) (26) . Expressions of HIF-1␣ and VEGF are reported to be activated in hypertrophied and failing heart (17, 26, 29, 30) , and the increased number of capillary vessels penetrating the interstitial spaces contribute to supply oxygen and nutrients to the cardiocytes for maintaining the structure and function of pressure-overloaded heart (29, 34) .
Guanylate cyclase is an enzyme that converts guanosine triphosphate to cyclic guanosine monophosphate (cGMP). Soluble guanylate cyclase (sGC) activated by nitric oxide has been shown to attenuate cardiovascular remodeling by elevating intracellular cGMP levels (6, 18) . We and others have previously reported that the pharmacological stimulation of sGC with BAY 41-2272 attenuated the adverse remodeling associated with systemic or pulmonary hypertension, suggesting that sGC-cGMP activation would be one of the important therapeutic targets for the treatment in the disorders (7, 22, 23) . However, the interaction between sGC-cGMP signaling and HIF-1␣ expression during mechanical load/ischemia in the heart is unknown. Therefore, we sought to examine whether the pharmacological stimulation of sGC-cGMP would affect the HIF-1␣-angiogenic pathway in cultured cardiomyocytes exposed to hypoxia and in pressure-overloaded heart.
MATERIALS AND METHODS
The present study was performed in accordance with the Animal Welfare Act and with approval of the University of Miyazaki Institutional Animal Care and Use Committee (2006-014-3, 2002-049-7). It also conformed with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (NIH publication no. 85-23, revised 1996) .
Cell culture. Cardiomyocytes were isolated from 1-day-old neonatal Wistar rats as described (38) . The cardiomyocytes were cultured on collagen type I-coated culture plates for 48 h with DMEM containing 15 mmol/l HEPES, 10% FBS, 10 g/ml insulin, 5 g/ml transferrin, 7 ng/ml sodium selenite, and 0.1 mmol/l bromodeoxyuridine (BrdU) at 37°C in a humidified atmosphere of 95% air-5% CO2 and further incubated in serum-free DMEM containing the same additives with the exception of BrdU for 48 h. The cells were cultured under normoxic (20% O2-5% CO2) or hypoxic (1% O2-5% CO2) conditions with or without 5 ϫ 10 Ϫ5 mol/l BAY 41-2272, a nonhydrolyzable cGMP analog (8-bromocGMP, 10 Ϫ3 mol/l; Calbiochem), and a selective protein kinase G inhibitor (KT-5823, 10 Ϫ6 mol/l; Calbiochem) that was added to the culture medium 30 min before hypoxia or BAY 41-2272. Specificity of BAY 41-2272 on concentration-dependent sGC stimulation has been addressed (33) , whereas this compound does not stimulate particulate guanylate, adenylate cyclase, or phosphodiesterase 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 [unpublished data, personal communication to Dr. Johannes-Peter Stasch, Bayer Schering Pharma (2, 39) ]. The concentrations of 8-bromo-cGMP and KT-5823 were determined by reflecting in accordance with previous studies (14, 35, 41) . After the cells had been cultured under normoxic or hypoxic conditions for 8 h, the nuclear extract was extracted according to the manufacturer's recommendations (Pierce). In addition, cultured cardiomyocytes treated with or without BAY 41-2272 for 10 min under normoxia were immediately collected for the cGMP assay as described previously (22) .
Animal experiment. Male Wistar rats (7 wk old; Charles River) weighing 200 -250 g were housed in a temperature-and lightcontrolled room (25 Ϯ 1°C; 12:12-h light-dark cycle) for 1 wk before use, with free access to normal rat chow and water. The rats were divided into the following three groups: a sham group (n ϭ 26) and two pressure-overloaded groups with (n ϭ 36) or without (n ϭ 58) BAY 41-2272 treatment. Pressure overload was induced by abdominal aortic constriction (AC) at the suprarenal level as previously described (10, 23) . In brief, a 22-gauge needle was placed adjacent to the abdominal aorta proximal to the renal artery and ligated tightly around the aorta and the adjacent needle. The needle was then removed, leaving the vessel constricted to the diameter of the needle. The sham group underwent identical surgical procedures but without constriction of the aorta. The BAY 41-2272 compound, supplied by Bayer HealthCare, was given by gastric gavage at a dose of 2 mg/kg two times a day for 14 days. The dose of BAY 41-2272 was chosen according to our previous study (22, 23) , in which 2 mg/kg was the subdepressor dose. The Datascience telemetric system was used to monitor the blood pressure and heart rate of four unrestricted, conscious rats in each study group, as described (23) . On day 14, the survived rats were anesthetized with pentobarbital sodium and killed by drawing blood from the thoracic aorta. After the whole heart and lung were weighed, left ventricle (LV) was frozen in liquid nitrogen or fixed in 4% paraformaldehyde and embedded in paraffin wax.
Immunohistochemistry and histological analysis. Immunohistochemical staining with HIF-1␣, von Willebrand factor (vWF) and monocyte/macrophages (CD68) was performed as reported (22, 36, 37) . Tissue sections 3 m thick fixed in 4% paraformaldehyde were pretreated before incubation with the primary antibodies: HIF-1␣, autoclaved at 121°C for 15 min; vWF, covered with proteinase K at 37°C for 15 min; CD68, covered with 0.05% pronase at 37°C for 10 min. Slides were stained with antibodies of HIF-1␣ (1:6,000, clone H1alpha67; Novus Biologicals), vWF (1:100; DAKOcytometion) or CD68 (1:600, Clone ED1; Chemicon) overnight at 4°C. The slide sections were then incubated with EnVision ϩ (DAKO) for 30 min, visualized with 0.05% 3,3Ј-diaminobenzidine containing hydrogen peroxide, and counterstained with hematoxylin. A catalyzed signal amplification system (CSA-DakoCytomation) was used for detecting HIF-1␣ antigen. Numbers of nuclei stained with HIF-1␣, capillary vessels stained with vWF, or monocyte/macrophages stained with CD68 were counted at magnifications of ϫ200 in a blinded manner. Western blot. Equal amounts of denatured total protein (20 g) or nuclear extract (10 g) from the LV or cultured cardiomyocytes were subjected to SDS-polyacrylamide gel as described (36) . In brief, the separated proteins electrically transferred onto polyvinylidene difluoride (PVDF) membranes were incubated with 5% skim milk. PVDF membranes were then incubated with a monoclonal antibody against HIF-1␣ (0.25 g/ml, clone H1alpha67; Novus Biologicals) or VEGF (0.4 g/ml, VG1; abcam) followed by a horseradish peroxidasecoupled secondary antibody. Immunoreactive bands were visualized with the ECL Plus detection kit (Amersham), and intensity of each band was analyzed densitometrically (Chemi Doc Documentation System; Bio-Rad).
Radioimmunoassay. cGMP level in the LV and in the cultured cells were determined using a radioimmunoassay kit (YAMASA Cyclic GMP Assay Kit) as previously described (22) .
Statistical analysis. All data were analyzed with SPSS software version 11.0 (SPSS). Values are expressed as means Ϯ SE. Differences between two groups were analyzed by Student's t-test, and differences between three groups were assessed using one-way ANOVA followed by Scheffé's test. Survival analysis was performed using the Kaplan-Meier method, and statistical significance was accepted at P Ͻ 0.05. and cGMP pathway on hypoxic induction of HIF-1␣ expression in cultured cardiomyocytes. Figure 1A shows that BAY 41-2272 (5 ϫ 10 Ϫ5 mol/l) significantly (P Ͻ 0.05) increased the intracellular cGMP level in cultured cardiomyocytes. At this concentration, BAY 41-2272 had little effect on the protein expression of HIF-1␣ under normoxic conditions, but significantly (P Ͻ 0.01) inhibited the hypoxia-induced expression of HIF-1␣ (Fig. 1B) . A cGMP analog, 8-bromo-cGMP (10 Ϫ3 mol/l), decreased the expression of HIF-1␣ induced by hypoxia (Fig. 1C) , whereas the inhibition of protein kinase G by KT-5823 (10 Ϫ6 mol/l) reversed the inhibitory effect elicited by BAY 41-2272 (Fig. 1D) .
RESULTS

In vitro effects of BAY
In vivo effects of BAY 41-2272 on systemic blood pressure, heart and lung weight, and cGMP level. As shown in Table 1 , the AC significantly (P Ͻ 0.01) increased the systolic and diastolic blood pressure levels compared with the sham group, whereas BAY 41-2272 had little effect on the elevation of blood pressure induced by pressure overload. In addition, the AC significantly (P Ͻ 0.01) increased the ratio of heart weight (mg/kg/day) (mg/kg/day) Data are expressed as means Ϯ SE; n ϭ 4 for systolic/diastolic blood pressure and heart rate; n ϭ 6 (sham), 10 {aortic constriction (AC)}, and 10 (AC ϩ BAY 41-2272) for the other parameters. LV, left ventricle. *P Ͻ 0.01 and †P Ͻ 0.05 vs. sham group.
to body weight compared with the sham group. However, it was not affected by the BAY 41-2272 treatment. BAY 41-2272 treatment had a trend to further increase the cGMP level in the LV of AC rats. Neither the heart rate nor the ratio of lung weight to body weight was changed in the respective groups. Figure 2A shows that the protein level of HIF-1␣ in the LV was significantly (P Ͻ 0.01) increased by the AC but was significantly (P Ͻ 0.05) decreased by the BAY 41-2272 treatment. As shown in Fig. 2B , the number of nuclei positive for HIF-1␣ in the cardiocytes was significantly (P Ͻ 0.01) increased by the AC but was significantly (P Ͻ 0.01) reduced by the treatment. Figure 3A shows that the protein level of VEGF in the LV was significantly (P Ͻ 0.01) increased by the AC but was significantly (P Ͻ 0.01) decreased by the BAY 41-2272 treatment. Figure 3B shows that the AC significantly (P Ͻ 0.01) increased the number of capillary vessels in the LV; however, BAY 41-2272 significantly (P Ͻ 0.01) decreased the number by 32%. Figure 4 shows that monocyte/macrophages significantly (P Ͻ 0.05) increased in number, accumulating around the intramyocardial arteries in the LV induced by pressure overload. BAY 41-2272 significantly (P Ͻ 0.05) decreased the number by 84%.
Effect of BAY 41-2272 on HIF-1␣ protein expression induced by pressure overload.
Effects of BAY 41-2272 on VEGF protein expression and number of capillary vessels induced by pressure overload.
Effect of BAY 41-2272 on infiltration of monocyte/macrophages induced by pressure overload.
Survival rate. Figure 5 shows that BAY 41-2272 administration in the AC rats significantly (P ϭ 0.0395) reduced the mortality over 14-day periods. Heart failure was the main cause of death, as confirmed by postmortem examination (pulmonary edema or hemorrhage was noted in most of the dead rats).
DISCUSSION
In this study, we report that pharmacological stimulation of sGC-cGMP decreased the hypoxia-induced HIF-1␣ expression in cultured cardiomyocytes. In addition, the subdepressor dose of BAY 41-2272 modulated the protein expressions of HIF-1␣ and VEGF and the number of capillary vessels induced by pressure overload.
The beneficial effects of stimulating sGC-cGMP on hemodynamics and remodeling in cardiovascular disorders have been demonstrated by ourselves and others (3, 6, 7, 18, 22, 23) . The present study extends our understanding of the important biological action for sGC-cGMP stimulation on improving the survival following the AC. However, the mechanisms by which the stimulation of sGC would affect the remodeling process remain to be defined. In this study, we specifically focused on the interaction between HIF-1␣ and sGC-cGMP in cardiomyocytes exposed to hypoxia and in LV during mechanical load. As shown, BAY 41-2272 reduced the hypoxiainduced HIF-1␣ expression in cultured cardiomyocytes, and this was accompanied by an increase in the intracellular cGMP level. In addition, a cGMP analog mimicked the effect of BAY 41-2272 on HIF-1␣ expression, whereas the inhibition of protein kinase G reversed the effect of BAY 41-2272 on HIF-1␣ expression induced by hypoxia in these cells. These results suggest that the activation of sGC/cGMP/protein kinase G signaling directly downregulates HIF-1␣ expression in cultured cardiomyocytes under hypoxic conditions. Mechanical load and/or tissue ischemia has been suggested to stimulate the HIF-1␣ expression during the pressure overload to the heart (17, 29) . Our study supports that the HIF-1␣ expression was increased in the pressure-overloaded LV. On the other hand, the role of sGC-cGMP signaling in modulating HIF-1␣ and VEGF expressions is reported to be dependent on oxygen supply (1, 5, 20, 27) . In the present study, BAY 41-2272 had little effect on the HIF-1␣ expression under normoxic conditions, but the compound significantly inhibited the expression under the hypoxia in cultured cardiomyocytes. Comparable with this, the protein expressions of HIF-1␣ and VEGF and the number of capillary vessels were attenuated by the compound in pressure-overloaded LV. As reported previously (30) , the immunoreactivity to HIF-1␣ accumulated in nuclei in the cardiocytes of LV induced by pressure overload, but it was significantly decreased by the treatment, implying that the change in HIF-1␣ expression in cardiocytes altered the angiogenic activity in a paracrine fashion (29) . Thus it seems that BAY 41-2272 counteracted the HIF-1␣ induction and angiogenic process during pressure overload. Mechanical load induces the multiple signal transductions, stimulating cardiomyocyte hypertrophy and fibrosis (28) . Despite the almost complete inhibition of pressure overload-induced increase in HIF-1␣ by treatment with BAY 41-2272, the corresponding increase in capillary density was partially inhibited, suggesting that HIF-1␣ was not the only stimulus driving the increased capillary density. It might be explained that other pathways also coordinate to induce the angiogenic gene transcription independent of HIF-1␣ during the pressure overload (21, 40 ).
It appears case-dependent whether angiogenesis is beneficial or detrimental in the progression of cardiovascular diseases (8, 12, 13, 16, 42) . As capillary vessels supply oxygen and nutrients to the cardiocytes in response to the demand, angiogenesis would be beneficial for maintaining the structure and function in ischemic or hypertrophied heart (29, 34) . On the other hand, because inflammatory cells are supposed to be recruited from circulating blood (4), one might raise the concern of whether the angiogenic pathway due to the upregulation of HIF-1␣ and VEGF expression during pressure overload is related to the inflammation and adverse remodeling (8, 9, 31) . Zhao et al. (42) have shown that the inhibition of nitric oxide/cGMP increases VEGF and stimulates inflammation and arteriosclerosis surrounding the intramyocardial coronary arteries. Conversely, the present study demonstrates that the stimulation of sGC-cGMP reduced VEGF expression and capillary numbers, concomitant with the decrease in infiltration of monocyte/macrophages in the LV induced by pressure overload. Sano and colleagues (29) reported that HIF-1␣-driven angiogenesis is critical for the preservation of cardiac structure and function, preventing the progression of heart failure. Although we found that BAY 41-2272 treatment resulted in the improvement of survival at a relatively early phase by pressure overload, it remains to be elucidated whether the long-term attenuation of the angiogenic pathway by the compound is beneficial in the development of heart failure following cardiac hypertrophy with pressure overload. Further studies are necessary to explore the effect of long-term stimulation of sGCcGMP inhibiting HIF-1␣ activity on the remodeling process. We have not assessed the mechanistic insight by which sGCcGMP inhibited the HIF-1␣ expression under hypoxia or during mechanical load in this study. However, the nitric oxide signaling pathway has been shown to inhibit the HIF-1 DNAbinding activity and transcriptional activity of HIF-1 target genes in hypoxic cells (11, 20, 32) . Therefore, we speculate that the sGC-cGMP stimulation with BAY 41-2272 might have a similar action of nitric oxide under those conditions. In addition, cGMP signaling has been shown to regulate a number of genes with regard to angiogenesis, inflammation, and extracellular matrix (25) . Thus it remains unknown whether all of these effects that we observed in this study are explicably mediated by the change in HIF-1␣. We have reported that the BAY 41-2272 treatment attenuated the fibrosis induced by pressure overload, accompanied by inhibiting the activity of angiotensin-converting enzyme and the subsequent decrease in the concentration of ANG II in the heart (23). HIF-1␣ drives not only angiogenesis but regulates the transcription of a number of genes for cell survival/proliferation, matrix metabolism, and vascular tone in a tissue-specific manner (15) . Alternatively, the present study might support that the HIF-1␣ contributes to the syntheses of tissue angiotensin-converting enzyme (19) and extracellular matrix-related genes (9) directly during pressure overload, whereas the sGC-cGMP stimulation would have reversed the remodeling of heart at least in part by modulating the HIF-1␣ expression.
In summary, this study supports that the HIF-1␣ expression is upregulated under hypoxia in the cultured cardiomyocytes and in the cardiocytes of pressure-overloaded LV. In addition, our data imply a possible involvement of HIF-1␣ expression modulated by the pharmacological sGC-cGMP stimulation in regulating the LV remodeling.
